Skip to main content
. 2019 Sep 10;8(9):386. doi: 10.3390/antiox8090386

Figure 6.

Figure 6

Protective effect of Delphinol® on bone loss in sRANKL and OVX-induced osteopenia mice. (A) Representative microcomputed tomography (micro-CT) images of the distal femurs of intact mouse (control), sRANKL-induced osteopenia mouse (vehicle), and MBE-treated sRANKL-induced osteopenia mice (MBE; 0.25, 0.5, 0.75 mg/mouse/day). (B) Microarchitectural indices of second trabecular spongiosa of the distal femurs as measured by micro-CT. (C) Representative micro-CT images of the distal femurs of sham-operated mouse (Sham), OVX-induced osteopenia mice (vehicle), and MBE-treated OVX-induced osteopenia mice (MBE; 0.25, 0.5, 0.75 mg/mouse/day). (D) Microarchitectural indices of second trabecular spongiosa of the distal femurs as measured by micro-CT. Values are expressed as mean ± SD (n = 5–8). *p < 0.05, **p < 0.01, ***p < 0.001.